Plan to give health care to every Californian moves forward

SACRAMENTO, Calif. (AP) -- California lawmakers pushed forward Wednesday with a proposal that would substantially remake the health care system of the nation's most populous state by replacing insurance companies with government-funded health care for everyone. The idea known as single-payer health care has long been popular on the left and is getting a new look in California as President Donald Trump looks to replace former President Barack Obama's health care law.

Conservatives back revised health bill, GOP moderates balk

WASHINGTON (AP) -- The moribund Republican health care bill received a jolt of life Wednesday when the conservative House Freedom Caucus endorsed a revised version of the measure. But a leading GOP moderate criticized the reshaped legislation as a conservative exercise in "blame-shifting and face-saving" that wasn't winning new support from party centrists, leaving its fate unclear.

Justices hear dispute over lower-cost biotech drugs sales

WASHINGTON (AP) -- The Supreme Court on Wednesday considered a dispute between rival drug companies that could affect how quickly life-saving generic medicines are available to the public. The case before the justices involves the cutting-edge field of biologics -- drugs made from living cells instead of chemicals. The drugs have led to major advances in treating cancer and other diseases, but often come with a massive price tag.

The Latest: GOP offers stopgap bill to fund government

WASHINGTON (AP) -- The Latest on efforts in Congress to repeal the health care law and agree on a spending bill to keep the government open (all times local): 11:30 p.m. Republicans controlling the House have unveiled a stopgap bill to keep the government open past a shutdown deadline of midnight Friday.

Hardball health care option may cost Trump and taxpayers

WASHINGTON (AP) -- Counting down to a budget deadline, the White House has toyed with a hardball health care tactic to force Democrats to yield on President Donald Trump's priorities. The administration just might eliminate billions of dollars in disputed "Obamacare" subsidies. But a study out Tuesday from a nonpartisan group suggests that could backfire.

FDA approves near-copy of Remicade for immune disorders

Federal regulators have approved an alternative version of Remicade, an expensive injected drug widely used for rheumatoid arthritis and other immune system disorders. The Food and Drug Administration said Friday that it approved Renflexis, developed by Samsung Bioepis Co. of South Korea. It will be marketed by its U.S. partner, Merck & Co. of Kenilworth, New Jersey. The companies refused to disclose the list price.

Johnson & Johnson says pricing competition squeezing sales

Increased pressure to cut medicine prices and an industry-wide slowdown in consumer health product sales is hurting health care giant Johnson & Johnson. Those factors, along with a bigger tax bill than a year ago, trimmed J&J's first-quarter profit slightly, but it still gave a rosier financial forecast for the year.

In Alaska, anxiety grows as debate over health care rages

JUNEAU, Alaska (AP) -- Going without health insurance is a risk. Going without it in Alaska can be a gamble of a much higher order, for this is a place unlike anywhere else in the U.S., a land of pitiless cold, vast expanses and dangerous, back-breaking work such as pulling fishing nets from the water or hauling animal carcasses out of the woods. And yet many people on the Last Frontier do not carry insurance.

How Trump insurance changes could affect coverage next year

A much tighter sign-up deadline and coverage delays will be waiting for some health insurance customers now that President Donald Trump's administration has finished a plan designed to stabilize shaky insurance markets. Shoppers will have a shorter time period to choose a 2018 plan and a harder time enrolling outside that window if they lose a job or have some other special circumstance that affects their coverage.